Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.
Duvic
Madeleine
M
Department of Dermatology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. mduvic@mdanderson.org
Chiao
Nor
N
Talpur
Rakhshandra
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009182:Mycosis Fungoides / Q000188:drug therapy / Q000628:therapy; D017893:Photopheresis / Q000009:adverse effects; D011446:Prospective Studies; D012074:Remission Induction; D012189:Retrospective Studies; D012751:Sezary Syndrome / Q000188:drug therapy / Q000628:therapy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000628:therapy; D016896:Treatment Outcome
D007155:Immunologic Factors